Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Terminated2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01313416Phase 2Terminated
Gemcitabine and CT-011 for Resected Pancreatic Cancer
Cancer of the PancreasNeoplasms PancreaticPancreas Cancer+2 more
PrincipalinvestigatorStart date: 2012-09-01
NCT01420965Phase 2Terminated
Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
Prostatic Neoplasms
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01313416Phase 2PrincipalInvestigator

Gemcitabine and CT-011 for Resected Pancreatic Cancer

Cancer of the PancreasNeoplasms PancreaticPancreas Cancer+2 more
Terminated
NCT01420965Phase 2PrincipalInvestigator

Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer

Prostatic Neoplasms
Terminated

All 2 trials loaded